News and Trends 27 Oct 2018 How Will Biotech Influence the Technology of the Future? Dutch designer Nicole Spit looks into the future of consumer biotech products with a series of speculative design objects being exhibited at the Dutch Design Week. Biotechnology is already revolutionizing healthcare. Soon, it might also take over our daily lives, but are we ready for it? Designer Nicole Spit wants to make us think about […] October 27, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2018 BASF Will Use CRISPR to Gene-Edit Crops and Microbes The German chemical giant BASF has obtained a non-exclusive license from the US Broad Institute for the use of CRISPR-Cpf1 gene-editing technology in agricultural and microbiological applications. CRISPR-Cas9 is a fast and easy technique for editing the genome that has gained worldwide fame. It has the potential for use in many applications such as in […] October 26, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2018 Danish Biotech Closes €79M Series C to Develop Inhaled Lung Disease Drug The Danish company Galecto Biotech can breathe a contented sigh. Its Series C funding round has raised €79M to finance a Phase II/III trial of its inhaled drug for a deadly lung disease. The amount raised is 30% higher than the company’s initial €60M goal, Galecto’s CEO, Hans Schambye, told me. “Being able to raise […] October 26, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 26 Oct 2018 This Biotech Develops Biodegradable Antimicrobial Paint For Your Yacht It is time to sail to Portugal for our Lisbon-based biotech of the week, BioMimetx. The company is developing biodegradable antimicrobial paint additives to help marine industries keep their surfaces clean of microbe buildup. Mission: Are you an environmentally conscious yacht owner who wants a clean boat bottom? If so, you are in luck, as […] October 26, 2018 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 25 Oct 2018 Invisible Eye Glucose Monitor Accurately Measures Sugar Levels In a small trial in the Netherlands, Dutch firm NovioSense has shown that its device for measuring blood sugar levels through tear fluid is comparable to current continuous glucose sensors. Currently, the standard method for people with diabetes to measure their blood sugar requires finger pricking multiple times per day, which can be painful and […] October 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Oct 2018 Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK A gene therapy for Parkinson’s disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London. Parkinson’s disease is a neurodegenerative disease, caused by a lack of the neurochemical dopamine in regions of the brain handling motor functions causing debilitating symptoms such as rigidity […] October 25, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 25 Oct 2018 Mastering the Competitive World of Immuno-oncology In recent years the oncology world has focused on using the immune system to target cancer, with CAR-T cell therapy and other success stories revolutionizing the field. Ulf Grawunder, CEO and founder of NBE Therapeutics, a company using antibody drug conjugates to target cancer, discussed how to navigate the competitive area of immuno-oncology at our […] October 25, 2018 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2018 UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy UK-based Microbiotica has received a £4M investment from Seventure’s fund dedicated to investments in the microbiome space. With Seventure coming on board as a new investor, Microbiotica has now raised a total of £12M since its foundation in 2016. The company, a spin-out of the Sanger Institute in Cambridge, seeks to find and exploit precise […] October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2018 15-Minute Cardiovascular Blood Test to Sell Across Europe French diagnostics company Magnisense has raised €5M to expand the sales of its emergency tests for heart attack and heart failure, which can be performed at home in just 15 minutes. The diagnostic technology developed by Magnisense, called MiAG, uses magnetic nanoparticles to detect extremely low quantities of cardiovascular biomarkers in the blood. “MiAG allows […] October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Oct 2018 Microbiome Biotech Enterome Signs Deal With Takeda Worth up to €600M The French biotech Enterome and Takeda are teaming up to fight Crohn’s disease, with a deal worth up to €600M. The two companies will collaborate in the development and commercialization of Enterome’s lead microbiome-targeting treatment currently in Phase I trials. Under the terms of the deal, Takeda will pay Enterome €44M upfront, and up to […] October 23, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 23 Oct 2018 Bridging the Academia-Industry Divide: Lessons from a Serial Biotech Entrepreneur What does it take to be a successful biotech entrepreneur? I put this and other similar questions to Dinko Valerio, a highly experienced Dutch geneticist turned serial entrepreneur and investor. While there are many great scientists, it takes a certain something to be able to cross over into industry and build a profitable business. Dinko […] October 23, 2018 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2018 Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating recurrent squamous cell carcinoma as standard therapy in a Phase II trial. Squamous cell carcinoma is a head and neck cancer that forms lesions in the mucous membranes of body cavities such as the mouth, nose and throat. “Patients are […] October 22, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email